Meta-analyses on the association of MTR A2756G and MTRR A66G polymorphisms with neural tube defect risks in Caucasian children

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 12, 2013, Pages 1166-1170

  Ouyang, Shengrong ^a   Liu, Zhuo ^a   Li, Yuanyuan ^a   Wu, Jianxin ^a  

^a CAPITAL INSTITUTE OF PEDIATRICS   (China)

Author keywords

Meta analyses; Methionine synthase; Methionine synthase reductase; Neural tube defects; Polymorphism

Indexed keywords

METHIONINE SYNTHASE; METHIONINE SYNTHASE REDUCTASE;

ALLELE; ARTICLE; CAUCASIAN; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MTR GENE; MTRR GENE; NEURAL TUBE DEFECT; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW;

5-METHYLTETRAHYDROFOLATE-HOMOCYSTEINE S-METHYLTRANSFERASE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FERREDOXIN-NADP REDUCTASE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEURAL TUBE DEFECTS; POLYMORPHISM, SINGLE NUCLEOTIDE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84880304317     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.777699     Document Type: Article

References (35)

1. van der Put NM, Eskes TK, Blom HJ. Is the common 677C-4T mutation in the methylenetetrahydrofolate reductase gene a risk factor for neural tube defects? A meta-analysis QJM 1997;90: 111-5.
2. Amorim MR, Lima MA, Castilla EE, Orioli IM. Non-Latin European descent could be a requirement for association of NTDs and MTHFR variant 677C4T: a meta-analysis. Am J Med Genet A 2007;143A:1726-32.
3. Wang XW, Luo YL, Wang W, et al. Association between MTHFR A1298C polymorphism and neural tube defect susceptibility: a metaanalysis. Am J Obstet Gynecol 2012;206:251.e1-7.
4. Doudney K, Grinham J, Whittaker J, et al. Evaluation of folate metabolism gene polymorphisms as risk factors for open and closed neural tube defects. Am J Med Genet A 2009;149A:1585-9.
5. Brouns R, Ursem N, Lindemans J, et al. Polymorphisms in genes related to folate and cobalamin metabolism and the associations with complex birth defects. Prenat Diagn 2008;28:485-93.
6. O'Leary VB, Mills JL, Pangilinan F, et al. Analysis of methionine synthase reductase polymorphisms for neural tube defects risk association. Mol Genet Metab 2005;85:220-7.
7. Gos M, Sliwerska E, Szpecht-Potocka A. Mutation incidence in folate metabolism genes and regulatory genes in Polish families with neural tube defects. J Appl Genet 2004; 45:363-8.
8. Gueant-Rodriguez RM, Rendeli C, Namour B, et al. Transcobalamin and methionine synthase reductase mutated polymorphisms aggravate the risk of neural tube defects in humans. Neurosci Lett 2003;344:189-92.
9. Zhu H, Wicker NJ, Shaw GM, et al. Homocysteine remethylation enzyme polymorphisms and increased risks for neural tube defects. Mol Genet Metab 2003;78:216-21.
10. De Marco P, Calevo MG, Moroni A, et al. Study of MTHFR and MS polymorphisms as risk factors for NTD in the Italian population. J Hum Genet 2002;47:319-24.
11. Johanning GL, Tamura T, Johnston KE, Wenstrom KD. Comorbidity of 5,10-methylenetetrahydrofolate reductase and methionine synthase gene polymorphisms and risk for neural tube defects. J Med Genet 2000;37:949-51.
12. Shaw GM, Todoroff K, Finnell RH, et al. Infant methionine synthase variants and risk for spina bifida. J Med Genet 1999;36: 86-7.
13. Christensen B, Arbour L, Tran P, et al. Genetic polymorphisms in methylenetetrahydrofolate reductase and methionine synthase, folate levels in red blood cells, and risk of neural tube defects. Am J Med Genet 1999;84:151-7.
14. Morrison K, Papapetrou C, Hol FA, et al. Susceptibility to spina bifida; an association study of five candidate genes. Ann Hum Genet 1998;62:379-96.
15. van der Put NM, van der Molen EF, Kluijtmans LA, et al. Sequence analysis of the coding region of human methionine synthase: relevance to hyperhomocysteinaemia in neural-tube defects and vascular disease. QJM 1997;90:511-7.
16. Pietrzyk JJ, Bik-Multanowski M, Sanak M, Twardowska M. Polymorphisms of the 5,10-methylenetetrahydrofolate and the methionine synthase reductase genes as independent risk factors for spina bifida. J Appl Genet 2003;44:111-3.
17. Wilson A, Platt R, Wu Q, et al. A common variant in methionine synthase reductase combined with low cobalamin (vitamin B12) increases risk for spina bifida. Mol Genet Metab 1999;67:317-23.
18. Relton CL, Wilding CS, Pearce MS, et al. Gene-gene interaction in folate-related genes and risk of neural tube defects in a UK population. J Med Genet 2004;41:256-60.
19. van der Linden IJ, den Heijer M, Afman LA, et al. The methionine synthase reductase 66A4G polymorphism is a maternal risk factor for spina bifida. J Mol Med (Berl) 2006;84:1047-54.
20. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986;7:177-88.
21. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22: 719-48.
22. Egger M, Davey SG, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-34.
23. Brody LC, Baker PJ, Chines PS, et al. Methionine synthase: highresolution mapping of the human gene and evaluation as a candidate locus for neural tube defects. Mol Genet Metab 1999; 67:324-33.
24. Doolin MT, Barbaux S, McDonnell M, et al. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 2002;71: 1222-6.
25. Boyles AL, Billups AV, Deak KL, et al. Neural tube defects and folate pathway genes: family-based association tests of gene-gene and gene-environment interactions. Environ Health Perspect 2006; 114:1547-52.
26. Shaw GM, Lu W, Zhu H, et al. 118 SNPs of folate-related genes and risks of spina bifida and conotruncal heart defects. BMC Med Genet 2009;10:49. doi: 10.1186/1471-2350-10-49.
27. Morrison K, Edwards YH, Lynch SA, et al. Methionine synthase and neural tube defects. J Med Genet 1997;34:958-960.
28. Relton CL, Wilding CS, Laffling AJ, et al. Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab 2004;81:273-81.
29. HY Al Farra. Methionine synthase polymorphisms frequencies distribution in the Jordanian population. J Pediatr Neurol 2011;9: 35-40.
30. Lucock M, Daskalakis I, Briggs D, et al. Altered folate metabolism and disposition in mothers affected by a spina bifida pregnancy: influence of 677c-4 t methylenetetrahydrofolate reductase and 2756a-4 g methionine synthase genotypes. Mol Genet Metab 2000;70:27-44.
31. Al FH. Methionine synthase polymorphisms (MTR 2756 A4G and MTR 2758 C4G) frequencies and distribution in the Jordanian population and their correlation with neural tube defects in the population of the northern part of Jordan. Indian J Hum Genet 2010;16:138-43.
32. Naushad SM, Devi AR. Role of parental folate pathway single nucleotide polymorphisms in altering the susceptibility to neural tube defects in South India. J Perinat Med 2010; 38:63-9.
33. Candito M, Rivet R, Herbeth B, et al. Nutritional and genetic determinants of vitamin B and homocysteine metabolisms in neural tube defects: a multicenter case-control study. Am J Med Genet A 2008;146A:1128-33.
34. Relton CL, Wilding CS, Laffling AJ, et al. Low erythrocyte folate status and polymorphic variation in folate-related genes are associated with risk of neural tube defect pregnancy. Mol Genet Metab 2004;81:273-81.
35. Doolin MT, Barbaux S, McDonnell M, et al. Maternal genetic effects, exerted by genes involved in homocysteine remethylation, influence the risk of spina bifida. Am J Hum Genet 2002;71: 1222-6.